Brief: Inhalation Sciences Sweden Q2 Operating Loss Widens To SEK 3.8 Million
Aug 26 (Reuters) - Inhalation Sciences Sweden AB ISAB.TE :
* Q2 OPERATING LOSS SEK 3.8 MILLION VERSUS LOSS SEK 0.8
MILLION
YEAR AGO
* Q2 NET SALES SEK 2.4 MILLION VERSUS SEK 2.7 MILLION YEAR
AGO
Source text for Eikon: ID:
Further company coverage: ISAB.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna